BioSpace News Archive

accesso Technology Group plc has announced its first ever healthcare patient experience partnership with Henry Ford Health System, a long-term agreement which will utilize The Experience Engine (TE2) platform to redefine how digital experience management software can power a greatly improved journey for patients, patient families and caregivers.

Unum Therapeutics announced the appointment of Karen J. Ferrante, MD, and Robert J. Perez to its Board of Directors.

MeiraGTx, a London and New York based gene therapy company, announced today the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to MeiraGTx’s gene therapy product candidate A002 for the treatment of patients with achromatopsia (ACHM) due to mutations in the CNGB3 gene.

Based on data provided by Arcview Market Research, legal cannabis sales in North America totaled $6.7 billion in 2016 and are projected to grow at a compound annual growth rate of 25 percent to an estimated $20.2 billion by 2021.

Vera Whole Health, the only direct-to-employer primary care provider in the Western United States that staffs full time health coaches on its care teams, received the Innovation in Health Care Delivery Award from Seattle Business magazine at the publication’s 2018 Leaders in Health Care Awards event last night.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that it entered into a Warrant Reprice Agreement whereby it received $1.03 million in warrant exercise proceeds.

Biogen and AbbVie announced the voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. The companies believe that characterizing the complex and evolving benefit/risk profile of ZINBRYTA will not be possible going forward given the limited number of patients being treated.

New advanced technology available at Brooks Rehabilitation, in partnership with Japan-based Cyberdyne, Inc.

Final approval of the listing on the TSX remains subject to InMed fulfilling certain customary listing conditions of the TSX on or before the TSX-imposed deadline of May 29, 2018.

“Excite Medical’s DRX9000 non-surgical spinal decompression system gives us the ability to provide our patients with the highest levels of treatment for a wide range of lower back pain,” Fraum explained.